Applicable to validated and difficult novel targets, such as GPCRs and ion channels Immunogen "agnostic"
- Pure proteins, protein preparations, peptides, whole cells, DNA
- Pure immunogen not required
>200 different recombinantly expressed monoclonals covering an array of affinities and epitopes arise per project
- Leads and backups immediately available
- No further affinity optimization of initial hits required
Screen for synergies for combination therapies, including bi-specifics